|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 326.65 CHF | +3.60% |
|
-0.94% | -3.93% |
| 06:58am | Baillie Gifford European repositions portfolio as asset value falls | AN |
| May. 13 | US FDA approves BeOne's drug for a type of blood cancer | RE |
| Capitalization | 255B 326B 279B 242B 448B 31,184B 452B 3,049B 1,184B 14,818B 1,224B 1,198B 51,577B | P/E ratio 2026 * |
16.9x | P/E ratio 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise value | 266B 339B 291B 252B 466B 32,442B 470B 3,172B 1,232B 15,416B 1,273B 1,246B 53,659B | EV / Sales 2026 * |
4.24x | EV / Sales 2027 * | 3.97x |
| Free-Float |
88.75% | Yield 2026 * |
3.13% | Yield 2027 * | 3.21% |
Last Transcript: Roche Holding AG
Trading Roche Holding AG
| 1 day | +3.62% | ||
| 1 week | -0.94% | ||
| Current month | -0.97% | ||
| 1 month | -0.88% | ||
| 3 months | -12.42% | ||
| 6 months | +10.21% | ||
| Current year | -3.93% |
| 1 week | 313 | 323.2 | |
| 1 month | 312 | 326.7 | |
| Current year | 291 | 374.9 | |
| 1 year | 243.9 | 374.9 | |
| 3 years | 212.9 | 374.9 | |
| 5 years | 212.9 | 404.2 | |
| 10 years | 206.35 | 404.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2023-03-14 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 2011-06-05 |
| Chief Operating Officer | - | 2025-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 1995-12-31 |
Severin Schwan
CHM | Chairman | 59 | 2023-03-14 |
| Director/Board Member | 73 | 2015-03-02 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.60% | -0.94% | +23.89% | +10.73% | 326B | ||
| +0.58% | +6.72% | +38.04% | +132.95% | 898B | ||
| -0.62% | +3.86% | +53.65% | +44.07% | 556B | ||
| +0.66% | +5.20% | +16.71% | +44.64% | 372B | ||
| -0.87% | +2.10% | +34.33% | +13.53% | 287B | ||
| +0.70% | +3.79% | +30.24% | +27.21% | 285B | ||
| -1.00% | +0.71% | +49.96% | -3.61% | 280B | ||
| +0.91% | +1.25% | -30.88% | -49.10% | 207B | ||
| -1.44% | -0.58% | +21.45% | +41.29% | 181B | ||
| -1.39% | -0.89% | +29.72% | +66.07% | 164B | ||
| Average | +0.12% | +1.74% | +26.71% | +32.78% | 355.64B | |
| Weighted average by Cap. | +0.28% | +2.19% | +31.72% | +51.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.71B 80.06B 68.59B 59.39B 110B 7,655B 111B 748B 291B 3,637B 300B 294B 12,661B | 65.29B 83.35B 71.41B 61.83B 114B 7,969B 115B 779B 303B 3,787B 313B 306B 13,181B |
| Net income | 15.33B 19.57B 16.76B 14.51B 26.87B 1,871B 27.09B 183B 71.05B 889B 73.43B 71.86B 3,094B | 16.38B 20.92B 17.92B 15.52B 28.73B 2,000B 28.96B 196B 75.95B 950B 78.5B 76.82B 3,308B |
| Net Debt | 10.31B 13.17B 11.28B 9.77B 18.08B 1,259B 18.23B 123B 47.81B 598B 49.41B 48.35B 2,082B | 3.44B 4.39B 3.76B 3.26B 6.03B 420B 6.08B 41.03B 15.94B 199B 16.47B 16.12B 694B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-05-07 | 315.30 CHF | -0.94% | 590,249 |
| 26-05-13 | 320.00 CHF | -0.47% | 611,255 |
| 26-05-12 | 321.50 CHF | +0.66% | 654,692 |
| 26-05-11 | 319.40 CHF | +1.30% | 724,136 |
| 26-05-08 | 315.30 CHF | -0.94% | 590,249 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROP Stock
Select your edition
All financial news and data tailored to specific country editions


















